Clinical trial · Observational
Hepatitis C Screening Paired With Mammography
Screening for the Hepatitis C Virus by TROD Paired With Mammography and Management of Chronic Hepatitis C in Women Aged 50 to 74 in the Agglomeration of Montpellier
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In France, a breast cancer screening is organized since 2004 for women aged 50-74. On the other hand, even though the seroprevalence of hepatitis C in the general French population is less than 1%, it is estimated that more than 75,000 people live with the virus without knowing it. To answer the WHO objective of eliminating hepatitis C by 2030 and in France by 2025, the investigators need to organize targeted screening. Women aged more than 50 years old, by their possible antecedents in life, are an exposed population. The investigators propose to pair the already organized breast cancer screening with a hepatitis-screening test by rapid diagnostic orientation test (TROD) and evaluate the adherence of women in this paired screening. For women with positive TROD, a specialized care will be organized.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Hepatitis C | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Adherence to the hepatitis C screening
- timeFrame
- At inclusion
- description
- Description: Number of women who have agreed to do the hepatitis C screening by rapid orientation diagnostic test (TROD) among the woman to whom it was offered.
Secondary outcomes (12)
- measure
- Percentage of positive hepatitis C TROD
- timeFrame
- At inclusion
- description
- Number of positive TROD among the number of TROD done
- measure
- Percentage of positive hepatitis C RNA
- timeFrame
- at 1 year after inclusion day
- description
- Number of positive HCV RNA blood samples among the positive TROD for hepatitis C
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 50 Years
- Maximum age
- 74 Years
Show eligibility criteria text
Inclusion Criteria: * \- Women aged 50-74 inclusive * Doing a breast cancer screening * Able to understand and complete a questionnaire on their own or with the help of a third party * Able to understand the study and follow the protocol * Having signed the consent form * With social security plan Exclusion Criteria: * \- Cannot sign the consent or follow the protocol * Under French legal protection measure (sauvegarde de justice, tutelle or curatelle)
References
Publications (1)
- BACKGROUNDMeszaros M, Coursier S, Nagot N, Moulis L, Taourel P, Pages-Bouic E, Fabre-Demard N, Trentini M, Pageaux GP, Donnadieu H. Screening for hepatitis C virus at the time of mammography using rapid diagnostic tests in women aged between 50 and 74 years (Mamm'OC NCT05067374). J Viral Hepat. 2024 Jul;31(7):416-422. doi: 10.1111/jvh.13947. Epub 2024 May 15. PMID 38749911